IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
219.91
+2.05 (0.94%)
At close: Oct 23, 2025, 4:00 PM EDT
219.91
0.00 (0.00%)
After-hours: Oct 23, 2025, 7:00 PM EDT
IQVIA Holdings Employees
IQVIA Holdings had 88,000 employees as of December 31, 2024. The number of employees increased by 1,000 or 1.15% compared to the previous year.
Employees
88,000
Change (1Y)
1,000
Growth (1Y)
1.15%
Revenue / Employee
$178,409
Profits / Employee
$14,057
Market Cap
37.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 88,000 | 1,000 | 1.15% |
| Dec 31, 2023 | 87,000 | 1,000 | 1.16% |
| Dec 31, 2022 | 86,000 | 7,000 | 8.86% |
| Dec 31, 2021 | 79,000 | 9,000 | 12.86% |
| Dec 31, 2020 | 70,000 | 3,000 | 4.48% |
| Dec 31, 2019 | 67,000 | 9,000 | 15.52% |
| Dec 31, 2018 | 58,000 | 3,000 | 5.45% |
| Dec 31, 2017 | 55,000 | 5,000 | 10.00% |
| Dec 31, 2016 | 50,000 | 13,900 | 38.50% |
| Dec 31, 2015 | 36,100 | 3,500 | 10.74% |
| Dec 31, 2014 | 32,600 | 4,400 | 15.60% |
| Dec 31, 2013 | 28,200 | 788 | 2.87% |
| Dec 31, 2012 | 27,412 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IQV News
- 2 days ago - IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025 - Business Wire
- 23 days ago - IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025 - Business Wire
- 27 days ago - ILMN Stock vs. IQV Stock - Forbes
- 5 weeks ago - IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships - Business Wire
- 6 weeks ago - IQVIA: A Positive Long-Term Outlook Despite Trump Legislation - Seeking Alpha
- 6 weeks ago - IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management - Business Wire
- 7 weeks ago - IQVIA names Michael Fedock as financial chief - Reuters
- 7 weeks ago - IQVIA Announces CFO Transition in Early 2026 - Business Wire